What's interesting about GeneDx's tumble is that its first-quarter performance was, on the surface, rather good. The figures released Wednesday revealed the DNA testing company managed to boost its ...
Zacks Investment Research on MSN
Will robust exome and genome revenues lift GeneDx's Q1 earnings?
GeneDx Holdings Corp. WGS is slated to report its first-quarter 2026 results on May 4, after the market closes. The renowned ...
View GeneDx Holdings Corp. Class A WGS stock quote prices, financial information, real-time forecasts, and company news from CNN.
In the latest quarter, 5 analysts provided ratings for GeneDx Hldgs (NASDAQ:WGS), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...
In the preceding three months, 6 analysts have released ratings for GeneDx Hldgs (NASDAQ:WGS), presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
GeneDx, which specializes in diagnostics for rare and ultra-rare genetic disorders, is helping to get kids the diagnostic attention they need as part of Diagnosis is Power. Currently, one in 10 ...
The company obliterated the consensus analyst estimates for its second quarter. Its double-digit growth rates were fueled by sales of exome and genome testing services. That earnings report, unveiled ...
GeneDx (NASDAQ:WSG) announced plans on Wednesday to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation, to create a leading platform for rare disease diagnostics and newborn ...
Shares of GeneDx Holdings Corp. (NASDAQ:WGS) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales ...
COO Bryan Dechairo sold 5,961 directly-held shares for a transaction value of approximately $510,900 on Feb. 4, 2026. The sale represented 100% of Mr. Dechairo's direct ownership, reducing his direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results